查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1388187

等离子市场、份额、规模、趋势、行业分析报告：按类型、按应用、按最终用途、按地区、按细分市场、预测，2023-2032年

Blood Plasma Market Share, Size, Trends, Industry Analysis Report, By Type (Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, Others); By Application; By End-Use; By Region; Segment Forecast, 2023- 2032
出版日期: | 出版商: Polaris Market Research | 英文 118 Pages | 商品交期: 最快1-2个工作天内

价格

根据Polaris市场研究公司的最新研究，预计到2032年，全球等离子市场规模将达到547.8767亿美元。 该报告提供了对当前市场动态的详细见解，并对未来市场成长进行了分析。

血浆市场正在经历显着成长，特别是由于血友病和地中海贫血等严重血液疾病的盛行率不断上升，每年影响数百名新生儿。 血浆是血液的液体成分，在运输各种血液成分方面发挥重要作用，A.B 型血的人尤其需要血浆。 血浆用于治疗烧伤、休克、创伤和凝血障碍，并有助于增加血液容积、预防休克和凝血支持。 製药公司使用血浆来製造治疗出血性疾病和免疫缺陷的药物。

市场扩张是由政府措施、社会意识增强、研发努力、医疗保健产业扩大、人口老化以及血浆衍生产品采用增加所推动的。 凝血因子 VIII 和免疫球蛋白等血浆衍生产品对于血液相关疾病的治疗至关重要。 先进的血浆衍生产品研发、策略製造、技术进步、庞大的患者基础和不断增加的医疗保健支出都有助于市场在 2022-2032 年预测期内的积极成长。

血浆市场正面临基因工程替代品的颠覆，这些替代品可以在不依赖人类血浆的情况下为各种医疗状况提供治疗。 生物工程蛋白质和凝血因子可以透过重组技术生产，减少对血浆的依赖。 这种竞争会影响定价和市场占有率。 基因工程替代品被认为更安全，因为它们消除了某些疾病和病症中与血浆衍生产品相关的病原体传播风险。

等离子市场报告亮点

2022年免疫球蛋白将占销售份额的45.4%，将在免疫反应以及自体免疫疾病和免疫缺陷疾病的治疗中发挥重要作用。

免疫缺陷疾病细分市场占 2022 年销售额的 28.7%，主要依靠免疫球蛋白等血浆衍生产品来治疗各种原发性免疫缺陷疾病。

到 2022 年，对于国际需求和公共卫生准备至关重要的血浆衍生产品的供应，北美将占全球市场的 45.5% 份额。

目录

第 1 章简介

第 2 章执行摘要

第 3 章研究方法

第 4 章全球血浆市场洞察

  • Plasma - 行业概况
  • 血浆市场动态
    • 促进因素和机会
      • 对血浆衍生疗法的需求不断增加
      • 老年人口的增加推动市场成长
    • 抑制因素和挑战
      • 高成本和重组替代品阻碍了市场成长
  • PESTEL 分析
  • 等离子市场的产业趋势
  • 价值链分析
  • COVID-19 感染的影响分析

第 5 章全球等离子市场，依类型

  • 主要发现
  • 简介
  • 白蛋白
  • 因子 VIII
  • 因子 IX
  • 免疫球蛋白
  • 超免疫球蛋白
  • 其他

第 6 章全球等离子体市场，依应用划分

  • 主要发现
  • 简介
  • 血友病
  • 低丙种球蛋白血症
  • 免疫缺乏疾病
  • 血管性血友病
  • 其他

第 7 章全球血浆市场，依最终用途划分

  • 主要发现
  • 简介
  • 医院
  • 诊所
  • 其他

第 8 章全球等离子市场（按地区）

  • 主要发现
  • 简介
    • 2019-2032 年按地区划分的血浆市场评估
  • 血浆市场 - 北美
    • 北美：血浆市场，按类型，2019-2032 年
    • 北美：血浆市场，依最终用途，2019-2032 年
    • 北美：血浆市场，依应用划分，2019-2032 年
    • 血浆市场－美国
    • 血浆市场 - 加拿大
  • 血浆市场 - 欧洲
    • 欧洲：血浆市场，依类型，2019-2032 年
    • 欧洲：血浆市场，依最终用途，2019-2032 年
    • 欧洲：血浆市场，依应用划分，2019-2032 年
    • 血浆市场 - 英国
    • 血浆市场 - 法国
    • 血浆市场 - 德国
    • 血浆市场 - 义大利
    • 血浆市场 - 西班牙
    • 等离子市场 - 荷兰
    • 血浆市场 - 俄罗斯
  • 血浆市场 - 亚太地区
    • 亚太地区：血浆市场（按类型），2019-2032 年
    • 亚太地区：血浆市场，依最终用途，2019-2032 年
    • 亚太地区：血浆市场，依应用划分，2019-2032 年
    • 血浆市场 - 中国
    • 血浆市场 - 印度
    • 血浆市场 - 马来西亚
    • 血浆市场 - 日本
    • 血浆市场 - 印度尼西亚
    • 血浆市场－韩国
  • 血浆市场 - 中东和非洲
    • 中东和非洲：血浆市场（按类型），2019-2032 年
    • 中东和非洲：血浆市场，依最终用途，2019-2032 年
    • 中东和非洲：血浆市场，按应用划分，2019-2032 年
    • 血浆市场 - 沙乌地阿拉伯
    • 血浆市场 - 阿拉伯联合大公国
    • 血浆市场 - 以色列
    • 血浆市场 - 南非
  • 血浆市场 - 拉丁美洲
    • 拉丁美洲：血浆市场，依类型，2019-2032 年
    • 拉丁美洲：血浆市场，依最终用途，2019-2032 年
    • 拉丁美洲：血浆市场，按应用划分，2019-2032 年
    • 血浆市场 - 墨西哥
    • 血浆市场 - 巴西
    • 血浆市场 - 阿根廷

第 9 章竞争态势

  • 扩张与收购分析
    • 放大
    • 收购
  • 伙伴关係/协作/协议/揭露

第 10 章公司简介

  • Biotest AG
  • CSL
  • GC Biopharma Corp
  • Grifols
  • Intas Pharmaceuticals Ltd
  • Kedrion S.p.A.
  • LFB
  • Octapharma AG
  • Sanquin
  • Takeda Pharmaceuticals
Product Code: PM1311

The global blood plasma market size is expected to reach USD 54,787.67 million by 2032, according to a new study by Polaris market research. The report "Blood Plasma Market Share, Size, Trends, Industry Analysis Report, By Type (Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, Others); By Application; By End-Use; By Region; Segment Forecast, 2023- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The blood plasma market is experiencing substantial growth due to the increasing prevalence of severe blood disorders, notably Hemophilia and Thalassemia, impacting hundreds of newborns annually. Blood plasma, the fluid component of blood, plays a crucial role in transporting various blood constituents and is particularly in demand from individuals with blood type A.B. It is used in treating burn, shock, trauma, and clotting disorders, aiding in blood volume, shock prevention, and clotting support. Pharmaceutical companies utilize plasma for producing treatments for bleeding disorders and immune deficiencies.

The market's expansion is driven by government initiatives, growing public awareness, research and development efforts, healthcare sector expansion, an aging population, and increased adoption of plasma-derived products. Plasma-derived products like coagulation factor VIII and immunoglobulins are essential for managing blood-related disorders. Research and development in advanced plasma-derived products, strategic manufacturing, technological advancements, a substantial patient base, and increased healthcare expenditure all contribute to the market's positive trajectory during the 2022 to 2032 forecast period.

The blood plasma market faces disruption from recombinant alternatives that offer treatments for various medical conditions without relying on human plasma. Biologically engineered proteins and clotting factors can be produced through recombinant technologies, reducing dependence on plasma. This competition can impact pricing and market share, as recombinant alternatives are perceived as safer, eliminating the risk of pathogen transmission associated with plasma-derived products in specific diseases and medical conditions.

Blood Plasma Market Report Highlights

Immunoglobulins dominated with 45.4% revenue share in 2022, serving vital roles in immune responses and treating autoimmune and immunodeficiency disorders.

Immunodeficiency Diseases segment accounted for 28.7% of revenue in 2022, primarily relying on blood plasma-derived products, like immunoglobulins, to manage various primary immunodeficiency disorders.

North America led the 2022 global market 45.5% share in supplying plasma-derived products, vital for international demand and public health preparedness.

The global key market players include: Biotest AG, CSL, GC Biopharma Corp, Grifols, Intas Pharmaceuticals Ltd, Kedrion S.p.A., LFB, Octapharma AG, Sanquin, Takeda Pharmaceuticals

Polaris market research has segmented the Blood Plasma market report based on Type, Application, End-User, and region:

Blood Plasma, Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Albumin
  • Factor VIII
  • Factor IX
  • Immunoglobulin
  • Hyperimmune Globulin
  • Others

Blood Plasma, Application Outlook (Revenue - USD Million, 2019 - 2032)

  • Hemophilia
  • Hypogammaglobinemia
  • Immunodeficiency Diseases
  • Von Willebrand's Disease
  • Others

Blood Plasma, End-User Outlook (Revenue - USD Million, 2019 - 2032)

  • Hospitals
  • Clinics
  • Others

Blood Plasma, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Blood Plasma Market Insights

  • 4.1. Blood Plasma - Industry Snapshot
  • 4.2. Blood Plasma Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Demand for Plasma-Derived Therapies
      • 4.2.1.2. Growing Geriatric Population Fuels the Market Growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Cost and Recombinant Alternatives Hampers the Growth of the Market
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Blood Plasma Market Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Blood Plasma Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • 5.3. Albumin
    • 5.3.1. Global Blood Plasma Market, by Albumin, by Region, 2019 - 2032 (USD Million)
  • 5.4. Factor VIII
    • 5.4.1. Global Blood Plasma Market, by Factor VIII, by Region, 2019 - 2032 (USD Million)
  • 5.5. Factor IX
    • 5.5.1. Global Blood Plasma Market, by Factor IX, by Region, 2019 - 2032 (USD Million)
  • 5.6. Immunoglobulin
    • 5.6.1. Global Blood Plasma Market, by Immunoglobulin, by Region, 2019 - 2032 (USD Million)
  • 5.7. Hyperimmune Globulin
    • 5.7.1. Global Blood Plasma Market, by Hyperimmune Globulin, by Region, 2019 - 2032 (USD Million)
  • 5.8. Others
    • 5.8.1. Global Other Blood Plasma Market, by Region, 2019 - 2032 (USD Million)

6. Global Blood Plasma Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • 6.3. Hemophilia
    • 6.3.1. Global Blood Plasma Market, by Hemophilia, by Region, 2019 - 2032 (USD Million)
  • 6.4. Hypogammaglobulinemia
    • 6.4.1. Global Blood Plasma Market, by Hypogammaglobulinemia, by Region, 2019 - 2032 (USD Million)
  • 6.5. Immunodeficiency Diseases
    • 6.5.1. Global Blood Plasma Market, by Immunodeficiency Diseases, by Region, 2019 - 2032 (USD Million)
  • 6.6. Von Willebrand's Disease
    • 6.6.1. Global Blood Plasma Market, by Von Willebrand's Disease, by Region, 2019 - 2032 (USD Million)
  • 6.7. Others
    • 6.7.1. Global Blood Plasma Market, by Other Applications, by Region, 2019 - 2032 (USD Million)

7. Global Blood Plasma Market, by End-Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • 7.3. Hospitals
    • 7.3.1. Global Blood Plasma Market, by Hospitals, by Region, 2019 - 2032 (USD Million)
  • 7.4. Clinics
    • 7.4.1. Global Blood Plasma Market, by Clinics, by Region, 2019 - 2032 (USD Million)
  • 7.5. Others
    • 7.5.1. Global Other Blood Plasma Market, by Region, 2019 - 2032 (USD Million)

8. Global Blood Plasma Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Blood Plasma Market Assessment, By Geography, 2019 - 2032 (USD Million)
  • 8.3. Blood Plasma Market - North America
    • 8.3.1. North America: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
    • 8.3.2. North America: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
    • 8.3.3. North America: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.3.4. Blood Plasma Market - U.S.
      • 8.3.4.1. U.S.: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.3.4.2. U.S.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.3.4.3. U.S.: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.3.5. Blood Plasma Market - Canada
      • 8.3.5.1. Canada: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.3.5.2. Canada.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.3.5.3. Canada: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • 8.4. Blood Plasma Market - Europe
    • 8.4.1. Europe: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
    • 8.4.2. Europe.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
    • 8.4.3. Europe: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.4. Blood Plasma Market - UK
      • 8.4.4.1. UK: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.4.2. UK.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.4.4.3. UK: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.5. Blood Plasma Market - France
      • 8.4.5.1. France: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.5.2. France.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.4.5.3. France: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.6. Blood Plasma Market - Germany
      • 8.4.6.1. Germany: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.6.2. Germany.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.4.6.3. Germany: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.7. Blood Plasma Market - Italy
      • 8.4.7.1. Italy: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.7.2. Italy.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.4.7.3. Italy: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.8. Blood Plasma Market - Spain
      • 8.4.8.1. Spain: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.8.2. Spain.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.4.8.3. Spain: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.9. Blood Plasma Market - Netherlands
      • 8.4.9.1. Netherlands: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.9.2. Netherlands.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.4.9.3. Netherlands: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.10. Blood Plasma Market - Russia
      • 8.4.10.1. Russia: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.10.2. Russia.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.4.10.3. Russia: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • 8.5. Blood Plasma Market - Asia Pacific
    • 8.5.1. Asia Pacific: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
    • 8.5.2. Asia Pacific.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
    • 8.5.3. Asia Pacific: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.5.4. Blood Plasma Market - China
      • 8.5.4.1. China: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.5.4.2. China.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.5.4.3. China: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.5.5. Blood Plasma Market - India
      • 8.5.5.1. India: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.5.5.2. India.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.5.5.3. India: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.5.6. Blood Plasma Market - Malaysia
      • 8.5.6.1. Malaysia: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.5.6.2. Malaysia.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.5.6.3. Malaysia: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.5.7. Blood Plasma Market - Japan
      • 8.5.7.1. Japan: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.5.7.2. Japan.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.5.7.3. Japan: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.5.8. Blood Plasma Market - Indonesia
      • 8.5.8.1. Indonesia: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.5.8.2. Indonesia.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.5.8.3. Indonesia: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.5.9. Blood Plasma Market - South Korea
      • 8.5.9.1. South Korea: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.5.9.2. South Korea.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.5.9.3. South Korea: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • 8.6. Blood Plasma Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
    • 8.6.3. Middle East & Africa: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.6.4. Blood Plasma Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.6.5. Blood Plasma Market - UAE
      • 8.6.5.1. UAE: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.6.5.2. UAE.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.6.5.3. UAE: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.6.6. Blood Plasma Market - Israel
      • 8.6.6.1. Israel: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.6.6.2. Israel.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.6.6.3. Israel: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.6.7. Blood Plasma Market - South Africa
      • 8.6.7.1. South Africa: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.6.7.2. South Africa.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.6.7.3. South Africa: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • 8.7. Blood Plasma Market - Latin America
    • 8.7.1. Latin America: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
    • 8.7.2. Latin America.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
    • 8.7.3. Latin America: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.7.4. Blood Plasma Market - Mexico
      • 8.7.4.1. Mexico: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.7.4.2. Mexico.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.7.4.3. Mexico: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.7.5. Blood Plasma Market - Brazil
      • 8.7.5.1. Brazil: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.7.5.2. Brazil.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.7.5.3. Brazil: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.7.6. Blood Plasma Market - Argentina
      • 8.7.6.1. Argentina: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.7.6.2. Argentina.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.7.6.3. Argentina: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Biotest AG
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. CSL
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. GC Biopharma Corp
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Grifols
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Intas Pharmaceuticals Ltd
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Kedrion S.p.A.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. LFB
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Octapharma AG
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Sanquin
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Takeda Pharmaceuticals
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development

List of Tables

  • Table 1 Global Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 2 Global Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 3 Global Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 4 Blood Plasma Market Assessment, By Geography, 2019 - 2032 (USD Million)
  • Table 5 North America: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 6 North America: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 7 North America: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 8 U.S.: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 9 U.S.: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 10 U.S.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 11 Canada: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 12 Canada: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 13 Canada: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 14 Europe: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 15 Europe: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 16 Europe: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 17 UK: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 18 UK: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 19 UK: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 20 France: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 21 France: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 22 France: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 23 Germany: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 24 Germany: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 25 Germany: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 26 Italy: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 27 Italy: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 28 Italy: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 29 Spain: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 30 Spain: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 31 Spain: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 32 Netherlands: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 33 Netherlands: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 34 Netherlands: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 35 Russia: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 36 Russia: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 37 Russia: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 38 Asia Pacific: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 39 Asia Pacific: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 40 Asia Pacific: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 41 China: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 42 China: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 43 China: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 44 India: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 45 India: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 46 India: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 47 Malaysia: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 48 Malaysia: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 49 Malaysia: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 50 Japan: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 51 Japan: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 52 Japan: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 53 Indonesia: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 54 Indonesia: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 55 Indonesia: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 56 South Korea: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 57 South Korea: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 58 South Korea: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 59 Middle East & Africa: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 60 Middle East & Africa: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 61 Middle East & Africa: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 62 Saudi Arabia: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 63 Saudi Arabia: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 64 Saudi Arabia: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 65 UAE: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 66 UAE: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 67 UAE: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 68 Israel: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 69 Israel: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 70 Israel: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 71 South Africa: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 72 South Africa: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 73 South Africa: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 74 Latin America: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 75 Latin America: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 76 Latin America: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 77 Mexico: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 78 Mexico: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 79 Mexico: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 80 Brazil: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 81 Brazil: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 82 Brazil: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 83 Argentina: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 84 Argentina: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 85 Argentina: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)

List of Figures

  • Figure 1. Global Blood Plasma Market, 2019 - 2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Application
  • Figure 7. Global Blood Plasma Market, by Application, 2022 & 2032 (USD Million)
  • Figure 8. Market by Type
  • Figure 9. Global Blood Plasma Market, by Type, 2022 & 2032 (USD Million)
  • Figure 10. Market by End-Use
  • Figure 11. Global Blood Plasma Market, by End-Use, 2022 & 2032 (USD Million)
  • Figure 12. Blood Plasma Market Assessment, By Geography, 2019 - 2032 (USD Million)
  • Figure 13. Strategic Analysis - Blood Plasma Market